ANI Pharmaceuticals Inc (ANIP) - Financial and Strategic SWOT Analysis Review
ANI Pharmaceuticals Inc (ANIP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
ANI Pharmaceuticals Inc (ANI) is a specialty pharmaceutical company that develops, manufactures and markets generic and branded prescription pharmaceuticals. The company offers pharmaceuticals for central nervous system (CNS) disorders, gastrointestinal, cancer, ophthalmic, metabolic and other diseases. ANI also conducts business as Contract Development and Manufacturing Organization (CDMO) supporting late-stage development to commercial manufacture of pharmaceutical products including coated/non-coated tablets and capsules, ointments, creams, non-sterile liquids, suspensions, and gels. It markets oncology products, complex formulations, hormones and steroids and controlled substances. The company sells products to wholesale distributors, group purchasing organizations, retail pharmacy chains and other pharmaceutical companies. ANI is headquartered in Baudette, Minnesota, the US.
ANI Pharmaceuticals Inc Key Recent Developments
Jun 15,2021: ANI Pharmaceuticals to Present at the Raymond James Human Health Innovation Conference 2021
Jun 01,2021: ANI Pharmaceuticals Announces Details of 2021 Virtual Annual Meeting of Stockholders
May 27,2021: ANI Pharmaceuticals to Present at Jefferies Virtual Healthcare Conference 2021
May 07,2021: ANI Pharmaceuticals Reports First Quarter 2021 Results
Apr 26,2021: ANI Pharmaceuticals to Discuss First Quarter 2021 Financial Results on May 7, 2021
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
ANI Pharmaceuticals Inc (ANI) is a specialty pharmaceutical company that develops, manufactures and markets generic and branded prescription pharmaceuticals. The company offers pharmaceuticals for central nervous system (CNS) disorders, gastrointestinal, cancer, ophthalmic, metabolic and other diseases. ANI also conducts business as Contract Development and Manufacturing Organization (CDMO) supporting late-stage development to commercial manufacture of pharmaceutical products including coated/non-coated tablets and capsules, ointments, creams, non-sterile liquids, suspensions, and gels. It markets oncology products, complex formulations, hormones and steroids and controlled substances. The company sells products to wholesale distributors, group purchasing organizations, retail pharmacy chains and other pharmaceutical companies. ANI is headquartered in Baudette, Minnesota, the US.
ANI Pharmaceuticals Inc Key Recent Developments
Jun 15,2021: ANI Pharmaceuticals to Present at the Raymond James Human Health Innovation Conference 2021
Jun 01,2021: ANI Pharmaceuticals Announces Details of 2021 Virtual Annual Meeting of Stockholders
May 27,2021: ANI Pharmaceuticals to Present at Jefferies Virtual Healthcare Conference 2021
May 07,2021: ANI Pharmaceuticals Reports First Quarter 2021 Results
Apr 26,2021: ANI Pharmaceuticals to Discuss First Quarter 2021 Financial Results on May 7, 2021
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
SECTION 1 - ABOUT THE COMPANY
ANI Pharmaceuticals Inc - Key Facts
ANI Pharmaceuticals Inc - Key Employees
ANI Pharmaceuticals Inc - Key Employee Biographies
ANI Pharmaceuticals Inc - Major Products and Services
ANI Pharmaceuticals Inc - History
ANI Pharmaceuticals Inc - Company Statement
ANI Pharmaceuticals Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
SECTION 2 – COMPANY ANALYSIS
Company Overview
ANI Pharmaceuticals Inc - Business Description
Product Category: Branded Pharmaceutical Products
Overview
Performance
Product Category: Contract Manufacturing Services
Overview
Performance
Product Category: Generic Pharmaceutical Products
Overview
Performance
Key Stats
Product Category: Royalty and Other Income
Performance
Geographical Segment: Canada
Performance
Geographical Segment: United States
Performance
R&D Overview
ANI Pharmaceuticals Inc - Corporate Strategy
ANI Pharmaceuticals Inc - SWOT Analysis
SWOT Analysis - Overview
ANI Pharmaceuticals Inc - Strengths
ANI Pharmaceuticals Inc - Weaknesses
ANI Pharmaceuticals Inc - Opportunities
ANI Pharmaceuticals Inc - Threats
ANI Pharmaceuticals Inc - Key Competitors
SECTION 3 – COMPANY FINANCIAL RATIOS
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES
ANI Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
ANI Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
ANI Pharmaceuticals Inc, Recent Deals Summary
SECTION 5 – COMPANY’S RECENT DEVELOPMENTS
Jun 15, 2021: ANI Pharmaceuticals to Present at the Raymond James Human Health Innovation Conference 2021
Jun 01, 2021: ANI Pharmaceuticals Announces Details of 2021 Virtual Annual Meeting of Stockholders
May 27, 2021: ANI Pharmaceuticals to Present at Jefferies Virtual Healthcare Conference 2021
May 07, 2021: ANI Pharmaceuticals Reports First Quarter 2021 Results
Apr 26, 2021: ANI Pharmaceuticals to Discuss First Quarter 2021 Financial Results on May 7, 2021
Mar 09, 2021: ANI Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Results Company Positioned for Sustainable Future Growth
Feb 17, 2021: ANI Pharmaceuticals strengthens leadership team to accelerate future growth
Feb 16, 2021: ANI Pharmaceuticals to Discuss Fourth Quarter and Full Year 2020 Financial Results on March 9, 2021
Nov 05, 2020: ANI Pharmaceuticals reports third quarter 2020 results
Aug 06, 2020: ANI Pharmaceuticals appoints experienced pharmaceutical executives, Jeanne Thoma and Antonio “Tony” Pera to Board of Directors
SECTION 6 – APPENDIX
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
ANI Pharmaceuticals Inc - Key Facts
ANI Pharmaceuticals Inc - Key Employees
ANI Pharmaceuticals Inc - Key Employee Biographies
ANI Pharmaceuticals Inc - Major Products and Services
ANI Pharmaceuticals Inc - History
ANI Pharmaceuticals Inc - Company Statement
ANI Pharmaceuticals Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
SECTION 2 – COMPANY ANALYSIS
Company Overview
ANI Pharmaceuticals Inc - Business Description
Product Category: Branded Pharmaceutical Products
Overview
Performance
Product Category: Contract Manufacturing Services
Overview
Performance
Product Category: Generic Pharmaceutical Products
Overview
Performance
Key Stats
Product Category: Royalty and Other Income
Performance
Geographical Segment: Canada
Performance
Geographical Segment: United States
Performance
R&D Overview
ANI Pharmaceuticals Inc - Corporate Strategy
ANI Pharmaceuticals Inc - SWOT Analysis
SWOT Analysis - Overview
ANI Pharmaceuticals Inc - Strengths
ANI Pharmaceuticals Inc - Weaknesses
ANI Pharmaceuticals Inc - Opportunities
ANI Pharmaceuticals Inc - Threats
ANI Pharmaceuticals Inc - Key Competitors
SECTION 3 – COMPANY FINANCIAL RATIOS
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES
ANI Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
ANI Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
ANI Pharmaceuticals Inc, Recent Deals Summary
SECTION 5 – COMPANY’S RECENT DEVELOPMENTS
Jun 15, 2021: ANI Pharmaceuticals to Present at the Raymond James Human Health Innovation Conference 2021
Jun 01, 2021: ANI Pharmaceuticals Announces Details of 2021 Virtual Annual Meeting of Stockholders
May 27, 2021: ANI Pharmaceuticals to Present at Jefferies Virtual Healthcare Conference 2021
May 07, 2021: ANI Pharmaceuticals Reports First Quarter 2021 Results
Apr 26, 2021: ANI Pharmaceuticals to Discuss First Quarter 2021 Financial Results on May 7, 2021
Mar 09, 2021: ANI Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Results Company Positioned for Sustainable Future Growth
Feb 17, 2021: ANI Pharmaceuticals strengthens leadership team to accelerate future growth
Feb 16, 2021: ANI Pharmaceuticals to Discuss Fourth Quarter and Full Year 2020 Financial Results on March 9, 2021
Nov 05, 2020: ANI Pharmaceuticals reports third quarter 2020 results
Aug 06, 2020: ANI Pharmaceuticals appoints experienced pharmaceutical executives, Jeanne Thoma and Antonio “Tony” Pera to Board of Directors
SECTION 6 – APPENDIX
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
LIST OF TABLES
ANI Pharmaceuticals Inc, Key Facts
ANI Pharmaceuticals Inc, Key Employees
ANI Pharmaceuticals Inc, Key Employee Biographies
ANI Pharmaceuticals Inc, Major Products and Services
ANI Pharmaceuticals Inc, History
ANI Pharmaceuticals Inc, Other Locations
ANI Pharmaceuticals Inc, Subsidiaries
ANI Pharmaceuticals Inc, Key Competitors
ANI Pharmaceuticals Inc, Ratios based on current share price
ANI Pharmaceuticals Inc, Annual Ratios
ANI Pharmaceuticals Inc, Annual Ratios (Cont...1)
ANI Pharmaceuticals Inc, Annual Ratios (Cont...2)
ANI Pharmaceuticals Inc, Interim Ratios
ANI Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
ANI Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
ANI Pharmaceuticals Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
ANI Pharmaceuticals Inc, Key Facts
ANI Pharmaceuticals Inc, Key Employees
ANI Pharmaceuticals Inc, Key Employee Biographies
ANI Pharmaceuticals Inc, Major Products and Services
ANI Pharmaceuticals Inc, History
ANI Pharmaceuticals Inc, Other Locations
ANI Pharmaceuticals Inc, Subsidiaries
ANI Pharmaceuticals Inc, Key Competitors
ANI Pharmaceuticals Inc, Ratios based on current share price
ANI Pharmaceuticals Inc, Annual Ratios
ANI Pharmaceuticals Inc, Annual Ratios (Cont...1)
ANI Pharmaceuticals Inc, Annual Ratios (Cont...2)
ANI Pharmaceuticals Inc, Interim Ratios
ANI Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
ANI Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
ANI Pharmaceuticals Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
LIST OF FIGURES
ANI Pharmaceuticals Inc, Performance Chart (2016 - 2020)
ANI Pharmaceuticals Inc, Ratio Charts
ANI Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
ANI Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021
ANI Pharmaceuticals Inc, Performance Chart (2016 - 2020)
ANI Pharmaceuticals Inc, Ratio Charts
ANI Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
ANI Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021